Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2020-06-25
2022-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer
NCT02664974
Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients
NCT03787537
Nutritional Risk Screening Nutritional Support Gastrointestinal Cancer
NCT06018246
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients
NCT06414122
A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies
NCT06997302
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Initial Diagnosis
Patients with initial diagnosis of a malignant condition of the gastrointestinal tract planned to receive cytostatic treatment.
No intervention - observational study only
No intervention - observational study only
Ongoing Cytostatic Treatment
Patients with a malignant condition of the gastrointestinal tract already receiving cytostatic treatment.
No intervention - observational study only
No intervention - observational study only
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention - observational study only
No intervention - observational study only
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ongoing cytostatic treatment of a known malignant condition of the gastrointestinal tract
Exclusion Criteria
* history of any other malignant tumor disease
* inability to provide consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medicine Greifswald
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali A Aghdassi, Professor
Role: PRINCIPAL_INVESTIGATOR
University Medicine Greifswald
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medicine Greifswald
Greifswald, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BB 071/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.